Noopept: The Complete Supplement Guide

Quick Reference Card

Overview

The Basics

Noopept is a synthetic compound developed in Russia in 1996 that belongs to the broader family of nootropics, substances taken to support cognitive function. It is sometimes grouped with the racetam family of compounds because of its structural similarity, though technically it is not a true racetam.

Noopept is often described as being up to 1,000 times more potent than piracetam on a dose-per-dose basis, meaning it achieves similar effects at much smaller amounts. It was developed at the Zakusov Institute of Pharmacology in Moscow and is sold as a prescription medication in Russia for improving learning, memory, and cognitive function, particularly after brain injuries like concussion or stroke.

In most Western countries, including the United States, Noopept is not approved as a drug or recognized as a dietary supplement. Despite this, it is widely available online and used by the nootropic community for cognitive enhancement.

The Science

Noopept (N-phenylacetyl-L-prolylglycine ethyl ester, GVS-111) is a synthetic dipeptide analog of piracetam, designed through peptide-based drug design at the State Zakusov Institute of Pharmacology, Moscow [11] [2]. The compound was synthesized based on the endogenous neuropeptide cycloprolylglycine, utilizing proline and glycine residues in a dipeptide configuration [11].

While commonly referenced as "1,000-fold more potent than piracetam," the actual potency ratio varies considerably depending on the measure used, ranging from 200x to 50,000x on a dose-per-dose basis [11]. The compound acts primarily as a prodrug for cycloprolylglycine, with the parent molecule being rapidly metabolized and undetectable in serum within 25 minutes of oral administration [11].

Noopept is registered as a pharmaceutical in Russia under registration number 015770, manufactured by JSC LEKKO Pharmaceuticals. Clinical study in patients with mild cognitive impairment of cerebrovascular and post-traumatic origin demonstrated decreased cognitive impairment, anxiolytic effects, and vegetostabilizing activity [2].

Chemical & Nutritional Identity

Noopept is structurally a dipeptide conjugate of piracetam, though it lacks the 2-oxo-pyrrolidine nucleus that defines the racetam class. It is a water-soluble proline-containing dipeptide structure. The compound's bioactivity is primarily attributed to its conversion to cycloprolylglycine, an endogenous neuropeptide, rather than direct activity of the parent molecule [11] [2].

Mechanism of Action

The Basics

Noopept works in your brain through several pathways, but the core mechanism is surprisingly simple: your body converts it into a naturally occurring brain molecule called cycloprolylglycine. Think of Noopept as a delivery vehicle that gets this helpful molecule into your brain more efficiently than the molecule could get there on its own.

Once converted, cycloprolylglycine influences how your brain cells communicate. It enhances the activity of glutamate receptors, which are involved in learning and forming new memories. It also boosts production of two important brain growth factors called BDNF and NGF, which support the health and growth of brain cells over time.

Some users describe Noopept as making their brain feel "sharper" or more alert. This may relate to its effects on brain wave patterns, which research has shown include increased alpha and beta wave activity, patterns associated with focused attention and cognitive processing.

The Science

Noopept's mechanism of action involves multiple neurochemical pathways:

Primary mechanism -- HIF-1 activation: The most recent mechanistic research identifies HIF-1 (Hypoxia-Inducible Factor 1) activation as the likely primary mechanism. Noopept (10 uM) selectively increases DNA-binding activity of HIF-1 in HEK293 cells without affecting 8 other transcription factors tested (CREB, NFAT, NF-kB, p53, STAT1, GAS, VDR, HSF1). Molecular docking confirms that the L-isomer (but not the pharmacologically inactive D-isomer) binds to the active site of prolyl hydroxylase 2 (PHD2), inhibiting HIF-1 degradation. This HIF-positive effect may explain Noopept's broad spectrum of neurochemical effects [2].

Neurotrophic factor upregulation: Single and chronic doses (0.5 mg/kg) increase both NGF and BDNF mRNA concentrations in rat hippocampus, with greater relative increase in NGF. No tolerance developed over 28 days of chronic dosing [3].

Cholinergic sensitization: Noopept exhibits a "cholinosensitizing" effect, stimulating neuronal responses to acetylcholine at concentrations from 10 pM to 1 uM in isolated neurons [11].

Nicotinic receptor involvement: Noopept (5 uM) increases action potential firing in GABAergic interneurons in hippocampal CA1 region, an effect abolished by alpha7 nAChR antagonists. This identifies alpha7 nicotinic acetylcholine receptors as an important site of action [4].

EEG modulation: Noopept (0.2 mg/kg) increases spindle-like activity and alpha wave function across all tested brain regions in rats, with enhanced beta 1 wave function in the right cortex and hippocampus. These effects are NMDA receptor-dependent, as they are attenuated by the NMDA antagonist CPP [11].

Neuroprotection: Noopept protects PC12 cells against Abeta25-35-induced toxicity through suppression of oxidative stress, reduction of intracellular calcium influx, stabilization of mitochondrial function, reduction of apoptosis, decrease in tau phosphorylation, and promotion of neurite outgrowth [6].

Absorption & Bioavailability

The Basics

Noopept is absorbed remarkably quickly after oral ingestion, reaching peak levels in your blood within about 7 minutes. However, there is an important catch: Noopept itself is not the active agent. Your body rapidly breaks it down into cycloprolylglycine, the molecule that actually does the work. This conversion happens so fast that Noopept itself is undetectable in your blood within about 25 minutes.

The estimated oral bioavailability is around 10%, meaning only about one-tenth of what you swallow reaches your bloodstream intact. Many users take Noopept sublingually (dissolved under the tongue) to potentially improve absorption by bypassing the digestive system.

The compound easily crosses the blood-brain barrier, reaching brain concentrations similar to blood concentrations within minutes. Despite the short half-life of the parent compound (about 16 minutes in rats), effects on brain function have been measured for over 70 minutes, likely because the active metabolite persists longer.

The Science

Oral administration at 50 mg/kg in rats demonstrates rapid GI tract absorption with a Tmax of 0.116 hours (approximately 7 minutes) and Cmax of 0.82 mcg/mL in serum. Serum concentrations and excretion kinetics of oral 50 mg/kg approximate those of 5 mg/kg injections, suggesting approximately 10% oral bioavailability [11].

Brain concentrations reach a Cmax of 1.289 mcg/mL at a Tmax of 0.115 hours following oral dosing, with minimal difference between serum and neural concentrations, confirming efficient blood-brain barrier penetration [11].

The parent compound has a half-life of approximately 16 minutes in rats and is undetectable in serum 25 minutes post-ingestion. However, EEG effects persist for 70+ minutes following injection (which has similar excretion kinetics to oral dosing), suggesting the bioactive metabolite cycloprolylglycine has a longer effective duration [11].

Interspecies differences in metabolism have been noted, with rats metabolizing Noopept more rapidly than humans. A formal human bioavailability study has not been conducted [11].

Cycloprolylglycine concentrations increase 2.4-fold in neural tissue following 5 mg/kg injections (from 2.8 nmol/g to 6.7 nmol/g wet brain weight), with conversion appearing to occur via deacetylation to phenylacetic acid and spontaneous reconfiguration [11].

Getting the dose right matters more than most people realize. Too little may be ineffective, too much wastes money or introduces risk, and inconsistency undermines both. Doserly tracks every dose you take, across every form, giving you a clear record of what you're actually consuming versus what you planned. The app helps you compare RDA recommendations against therapeutic ranges discussed in the research, so you can see exactly where your intake falls. If you switch forms, say from a standard capsule to a liposomal liquid, Doserly adjusts your tracking to account for different bioavailabilities. Pair that with smart reminders that keep your timing consistent, and the precision that makes a real difference in outcomes becomes effortless.

Research & Clinical Evidence

The Basics

Most of what we know about Noopept comes from animal studies and a small number of human trials conducted in Russia. The research paints an interesting picture, but it is important to understand that the evidence base is thin by Western clinical standards.

The most significant human study tested Noopept in 53 people with cognitive problems caused by either blood vessel damage to the brain or physical trauma. Over 56 days, Noopept at 20 mg daily improved cognitive scores more effectively than piracetam at 1,200 mg daily. It also helped patients with trauma-related cognitive problems, where piracetam did not. However, this study was not placebo-controlled, which limits how much weight we can give the results.

Animal studies have shown more dramatic results, including protection against various forms of brain damage and restoration of memory in models of Alzheimer's disease. Noopept has also shown ability to increase levels of brain growth factors (BDNF and NGF) in rat brains without developing tolerance over 28 days.

Importantly, no published studies have tested whether Noopept improves cognition in healthy humans or animals. All positive findings are in models of brain injury or disease.

The Science

Human clinical evidence:

A comparative study (n=53; 41 completers) examined Noopept 20 mg/day versus piracetam 1,200 mg/day over 56 days in patients with cerebrovascular insufficiency (n=37) and post-traumatic cerebral insufficiency (n=17). Noopept demonstrated superior improvement in global MMSE scores and was effective across both patient populations, while piracetam was effective only in vascular disease patients. Side effects were 1.8-fold less frequent with Noopept. Improvements were noted in fatigue, anxiety, irritability, apathy, and affective lability in both groups. Noopept additionally improved mood, sleep, and wakefulness in vascular damage patients. However, no placebo arm limits causal inference [11].

Neuroprotection -- Alzheimer's disease models:

In NMRI mice following olfactory bulbectomy (AD-like model), Noopept (0.01 mg/kg for 21 days) restored spatial memory and increased serum antibody levels to oligomers of Abeta(25-35) peptide prefibrillar aggregates. Enhancement of immune response to amyloid prefibrils may attenuate neurotoxic consequences of fibrillization [5].

In the beta-amyloid25-35 injection model, 0.5 mg/kg Noopept injections for 7 days prior to treatment fully prevented amnesiac properties of amyloid injections, with some rehabilitative effects when administered post-insult [11].

In PC12 cells, Noopept demonstrated neuroprotective effects against Abeta25-35-induced toxicity through multiple pathways including mitochondrial stabilization, apoptosis reduction, tau phosphorylation decrease, and neurite outgrowth promotion [6].

Neurotrophic factors:

NGF and BDNF mRNA expression increased in rat hippocampus following both acute and chronic (28-day) Noopept administration at 0.5 mg/kg. No tolerance developed with chronic dosing; the neurotrophic effect was potentiated over time [3].

Dose-response (animal):

A bimodal dose-response pattern was observed in amnesia models: oral doses of 0.5 mg/kg and 10 mg/kg were effective for memory retention, while intermediate (1.2 mg/kg) and high (30 mg/kg) doses were ineffective. Estimated effective human doses correlate to approximately 0.08 mg/kg and 1.6 mg/kg [11].

Key limitation: No studies exist examining Noopept in healthy humans or animals for cognitive enhancement purposes. All positive findings are in models characterized by existing brain damage or disease.

Evidence & Effectiveness Matrix

Categories not scored (insufficient data): Fat Loss, Muscle Growth, Weight Management, Appetite & Satiety, Food Noise, Stress Tolerance, Motivation & Drive, Emotional Aliveness, Libido, Sexual Function, Joint Health, Inflammation, Pain Management, Recovery & Healing, Physical Performance, Gut Health, Digestive Comfort, Nausea & GI Tolerance, Skin Health, Hair Health, Heart Health, Blood Pressure, Heart Rate & Palpitations, Hormonal Symptoms, Temperature Regulation, Fluid Retention, Body Image, Immune Function, Bone Health, Cravings & Impulse Control, Social Connection, Treatment Adherence, Withdrawal Symptoms, Daily Functioning.

Benefits & Potential Effects

The Basics

Noopept's potential benefits center on cognitive function and brain health. The most commonly reported positive effects include improved memory formation and recall, enhanced verbal fluency, better focus during demanding cognitive tasks, and a subtle mood-brightening effect.

However, it is critical to set realistic expectations. In healthy individuals, there is no published clinical evidence that Noopept enhances cognition. The benefits observed in research are limited to people with existing brain injuries or cognitive decline. Community reports from healthy users are mixed, with many describing effects as subtle at best and others experiencing no noticeable benefit at all.

For those who do respond positively, the benefits most commonly reported are improved word recall, easier sentence formation, and a general sense of mental clarity. Some users report enhanced sensory perception, including brighter colors and increased appreciation of music. These effects tend to be dose-dependent and build over 1-2 weeks of consistent use.

The Science

Documented benefits (in cognitively impaired populations):

• Improved MMSE scores relative to piracetam over 56 days in patients with cerebrovascular and post-traumatic cognitive insufficiency [11]
• Reduced fatigue, anxiety, irritability, apathy, and affective lability [11]
• Improved mood, sleep, and wakefulness in vascular damage patients [11]

Mechanistic benefits (animal/in-vitro):

• NGF and BDNF mRNA upregulation in hippocampus without tolerance over 28 days, with potential implications for long-term memory consolidation and neuronal health [3]
• Neuroprotection against amyloid beta toxicity: restored spatial memory and increased immunoreactivity to amyloid oligomers in AD models [5]
• Protection against oxidative stress, excitotoxicity, scopolamine-induced amnesia, compression damage, cerebral hypoxia, and photothrombosis [11]
• Alpha-synuclein fibrillization toward less cytotoxic beta-sheet formations, with potential Parkinson's disease relevance [11]

Immunomodulatory effects: Augmented phagocytic index of macrophages, increased splenocyte proliferation (70.4%), and enhanced T-cell proliferation (16.2%) with chronic dosing [11].

Reading about potential benefits gives you a framework. Seeing whether those benefits are showing up in your own body turns knowledge into confidence. Doserly lets you track the specific health markers relevant to this supplement, building a personal dataset that captures what's actually changing week over week. The app's AI analytics go further than simple logging. By correlating your supplement intake with the biomarkers and health outcomes you're tracking, Doserly surfaces patterns you might miss on your own, like whether a dose adjustment three weeks ago corresponds to the improvement you're noticing now.

Side Effects & Safety Considerations

The Basics

Noopept is generally considered to have a favorable safety profile within the recommended dose range, but several side effects warrant attention.

The most commonly reported side effect in community discussions is increased irritability. Many users describe becoming easily frustrated, impatient, or outright angry over minor issues, sometimes to a degree that interferes with relationships and daily life. This appears to be distinct from the cognitive effects and can occur even when the mental clarity benefits are present.

Short-term memory impairment is another paradoxical concern. Despite being marketed for memory enhancement, some users report worse short-term memory, particularly at higher doses. This effect has been noted across multiple independent reports.

Headaches are common and are generally attributed to acetylcholine depletion. The nootropics community near-universally recommends taking a choline source (Alpha-GPC or CDP-choline) alongside Noopept to prevent this.

Other reported side effects include insomnia, emotional blunting or numbness, elevated blood pressure, and allergic reactions.

The Science

Clinical safety data: In the 56-day comparative study, Noopept (20 mg/day) demonstrated a 1.8-fold lower side effect incidence compared to piracetam (1,200 mg/day), with both treatments generally well tolerated [11].

Manufacturer contraindications (JSC LEKKO Pharmaceuticals):

• Persons under age 18
• Pregnant or lactating women
• Kidney or liver disease
• Hypertension (can cause blood pressure elevation)
• Lactose sensitivity (due to excipients in commercial formulation)
  [10]

Reported adverse effects:

• Increased sleep disturbance and irritability [1] [10]
• Allergic reactions [10]
• Blood pressure elevation [10]

Community-reported effects (not in clinical literature):

• Short-term memory impairment at higher doses (paradoxical)
• Emotional blunting and reduced social engagement
• Severe irritability ("hulked out" -- multiple independent reports)
• Rapid tolerance development
• Brain fog at excessive doses (60+ mg)

No long-term safety studies exist. Noopept is not GRAS (Generally Recognized as Safe) in the United States [10].

Noopept should not be taken by people with high blood pressure or those taking blood pressure-lowering medication or stimulant medication [10].

Dosing & Usage Protocols

The Basics

The typical dose range for Noopept is 10-30 mg per day, taken for up to 56 days at a time. The Russian manufacturer recommends 10 mg twice daily (morning and afternoon) after eating, with treatment courses of 1.5 to 3 months followed by a one-month break.

Many users find that starting at the lower end (10 mg once daily) and gradually increasing is the safest approach. Sublingual administration (dissolving under the tongue) is popular in the nootropics community and may improve absorption and speed of onset.

A choline source such as Alpha-GPC (300-600 mg) or CDP-choline (250-500 mg) is widely recommended alongside Noopept to prevent headaches.

The Science

Manufacturer-recommended protocol (JSC LEKKO Pharmaceuticals):

• 10 mg twice daily (morning and afternoon)
• Take after meals
• Course duration: 1.5-3 months
• Rest period: 1 month before repeating
  [10]

Research-based dosing:

• Clinical trial dose: 20 mg/day (two 10 mg doses) for 56 days [11]
• Examine.com general recommendation: 10-30 mg once daily for up to 56 days [11]

Dosing frequency note: The manufacturer recommends split dosing (10 mg twice daily), which aligns with the clinical trial protocol (20 mg/day in two divided doses) and the compound's short half-life (~16 min for the parent molecule). Examine.com's once-daily recommendation (10-30 mg) may reflect a simplified protocol for compliance. Both approaches are represented in the literature; split dosing is better supported by the pharmacokinetic profile [10] [11].

Animal dose translation:

• Effective rat oral doses: 0.5 mg/kg and 10 mg/kg (bimodal response)
• Estimated effective human doses: approximately 0.08 mg/kg (5.6 mg for 70 kg person) and 1.6 mg/kg (112 mg for 70 kg person) [11]
• Intermediate doses (1.2 mg/kg in rats, ~0.192 mg/kg human equivalent) were ineffective

Administration routes:

• Oral: Standard route with ~10% estimated bioavailability
• Sublingual: Widely used in community, potentially faster onset by bypassing first-pass metabolism; no formal bioavailability comparison
• Intranasal: Some community members use nasal spray; limited formal data

What to Expect (Timeline)

Week 1 (Days 1-7):
Some users report noticeable effects within the first few days: subtle improvements in mental clarity, enhanced sensory perception (brighter colors, improved music appreciation), and a mild mood lift. Others report no perceptible effects at all during the first week. Headaches may occur if not supplementing with choline.

Weeks 2-3:
Many users report that Noopept's effects become more apparent after about 2 weeks of consistent use. This aligns with the neurotrophic factor upregulation timeline seen in animal studies (BDNF/NGF increases with chronic dosing). Irritability may emerge during this period.

Weeks 4-8 (Full Course):
The clinical trial demonstrated improvements in cognitive scores over 56 days. Community reports suggest this is when the full benefit profile stabilizes. However, some users report tolerance development beginning in this timeframe, with diminishing effects despite continued use.

After Stopping:
The manufacturer recommends a one-month break after 1.5-3 months of use. Some community members report that tolerance may persist for extended periods (weeks to months). The subchronic "buildup effect" noted in research suggests benefits may not immediately disappear upon cessation.

Timelines in the research give you a general idea of when to expect results, but your body has its own schedule. Doserly tracks your progress against those benchmarks, letting you see whether your experience aligns with typical response curves or whether something in your protocol might need adjusting. By logging biomarkers and subjective outcomes alongside your supplement intake, you build a personal timeline that shows exactly when changes started appearing and how they've progressed.

Interactions & Compatibility

Synergistic

• Choline sources (Alpha-GPC, CDP-choline): Near-universally recommended co-supplement. Noopept's cholinergic mechanism may increase acetylcholine demand, and choline supplementation helps prevent associated headaches.
• Piracetam: Some users combine at lower doses of each. Both modulate glutamate signaling through different specific mechanisms.
• L-theanine: Commonly stacked for anxiolytic support and to smooth any stimulatory edge.

Caution / Avoid

• Blood pressure medications: Noopept may elevate blood pressure. Concurrent use with antihypertensives requires monitoring [10].
• Stimulant medications: Noopept has mild psychostimulatory properties. Combined stimulant load should be considered [10].
• Anticholinergics: Given Noopept's cholinosensitizing mechanism, interaction potential exists with anticholinergic medications.
• Other racetams (high-dose combinations): Risk of "over-cognition" with excessive glutamate receptor modulation. Community advises caution stacking multiple racetam-class compounds at full doses.

Condition-Specific Contraindications:

• Hypertension (uncontrolled)
• Kidney disease
• Liver disease
• Pregnancy and lactation
• Under 18 years of age
  [10]

Cross-links will be expanded as more supplement guides are published.

How to Take / Administration Guide

Oral (standard):
Take 10 mg with or shortly after a meal. If splitting doses, take the second dose in the early afternoon (not late evening, to avoid sleep disruption). Swallow with water.

Sublingual:
Place powder or allow tablet to dissolve under the tongue. Hold for 30-60 seconds before swallowing. Taste is commonly described as unpleasant ("old socks"). Sublingual administration may provide faster onset and potentially improved bioavailability.

Timing considerations:

• Take in the morning and/or early afternoon
• Avoid evening dosing due to mild psychostimulatory effects
• Some users find effects best when taken 1 hour before cognitively demanding work
• Take with a choline source (Alpha-GPC 300-600 mg or CDP-choline 250-500 mg)

Cycling protocol:
Follow the manufacturer's recommendation of 1.5-3 months on, 1 month off. Community experience suggests cycling may help prevent tolerance development. Some users cycle more aggressively (1-2 weeks on, 1 week off) to maintain effectiveness.

Choosing a Quality Product

Purchasing quality Noopept presents unique challenges because it occupies a regulatory gray area in most Western countries.

Key quality concerns:

• Noopept is not approved as a dietary supplement in the U.S., meaning products do not fall under DSHEA regulatory oversight
• No major third-party testing programs (USP, NSF International, ConsumerLab) currently certify Noopept products
• Products marketed as cognitive enhancement supplements have been found to contain undisclosed amounts of Noopept and related compounds, raising quality and safety concerns [10]
• The FDA has specifically determined that Noopept "is not a dietary supplement or conventional food" [7]

What to look for:

• Products from vendors that provide Certificates of Analysis (CoA) with third-party purity testing
• HPLC or mass spectrometry verification of compound identity and purity
• Vendors who specify the isomeric form (L-isomer is the active form; D-isomer is inactive)
• Clear labeling of exact dose per serving

Red flags:

• Products making explicit disease treatment claims ("treats Alzheimer's," "cures brain damage")
• Proprietary blends that do not specify Noopept content
• Unusually low prices without verifiable testing
• Products combining Noopept with other undisclosed synthetic compounds

Storage & Handling

Noopept powder should be stored at room temperature in a dry, cool place, protected from direct light and moisture. The compound is stable in its powder form under normal storage conditions.

Keep tightly sealed in its original container or an airtight amber glass container. Avoid exposure to humidity, as Noopept is water-soluble and may degrade with moisture exposure.

No specific refrigeration requirements have been documented, but storing in a cool environment may extend shelf life. Capsule and tablet forms should be kept in blister packs or sealed containers to maintain potency.

Signs of degradation may include color changes (yellowing beyond the normal light yellow), clumping, or an unusual odor. If degradation is suspected, discard and replace.

Lifestyle & Supporting Factors

Noopept does not work in isolation. The following lifestyle factors can significantly influence whether you experience cognitive benefits:

Sleep: Adequate sleep is foundational for any nootropic to work. One rigorous self-tester who tracked brain fog for 6 months concluded that fixing sleep, vitamin D, and iron deficiency did more for cognition "than every nootropic stack combined."

Choline intake: Both dietary and supplemental choline support Noopept's cholinergic mechanism. Dietary sources include eggs, liver, and soybeans. Supplemental Alpha-GPC or CDP-choline is recommended alongside Noopept.

Exercise: Regular physical activity enhances cerebral blood flow and BDNF production, which may complement Noopept's neurotrophic mechanisms.

Foundational nutrition: Vitamin D, magnesium, and iron status should be optimized before relying on nootropic compounds for cognitive enhancement.

Monitoring recommendations:

• Track cognitive outcomes subjectively (focus, memory, mood) using a simple daily log
• Consider baseline and follow-up blood pressure monitoring given the blood pressure elevation risk
• If using for extended periods, periodic assessment of kidney and liver function is prudent given the manufacturer's contraindication warnings

Regulatory Status & Standards

United States:

• Noopept is NOT approved by the FDA as a drug
• Noopept is NOT recognized as a dietary supplement under DSHEA
• The FDA considers Noopept to be a synthetic compound that does not qualify for dietary supplement classification [7]
• Multiple FDA warning letters have been issued to companies selling Noopept products with unapproved drug claims [7] [8]
• Products continue to be sold online despite regulatory actions

Russia:

• Approved pharmaceutical drug (registration number 015770)
• Manufactured by JSC LEKKO Pharmaceuticals
• Indicated for improving learning, memory, and cognitive function after brain damage

European Union:

• Piracetam (structural relative) is classified as a prescription drug in the EU
• Noopept regulatory status varies by member state
• Not approved under centralized EU procedure

Athlete-specific considerations:

• Noopept is NOT explicitly listed on the 2026 WADA Prohibited List by name
• However, WADA's S0 category prohibits "any pharmacological substance which is not addressed by any of the subsequent sections of the List and with no current approval by any governmental regulatory health authority for human therapeutic use"
• Since Noopept lacks approval from major Western regulatory authorities, the S0 provision could potentially apply
• No third-party sport certification programs (NSF Certified for Sport, Informed Sport, Cologne List) certify Noopept products
• Athletes subject to anti-doping testing should consult their Anti-Doping Organization before using Noopept
• Products purchased online may contain undisclosed substances that ARE explicitly prohibited [9]

Athletes subject to drug testing should exercise extreme caution with Noopept. The WADA S0 "non-approved substances" catch-all category may apply, and no certified-for-sport Noopept products exist.

Frequently Asked Questions

Is Noopept legal to buy in the United States?
Noopept occupies a regulatory gray area. While the FDA has stated it is not a dietary supplement and has issued warning letters to sellers, it is not a controlled substance. Products continue to be sold online. Buyers should be aware they are purchasing a compound that the FDA does not recognize as safe or effective for any use.

How does Noopept compare to piracetam?
Noopept is structurally related to piracetam but works at much lower doses (10-30 mg vs. 1,200-4,800 mg). In the only head-to-head human study, Noopept (20 mg) outperformed piracetam (1,200 mg) on cognitive scores over 56 days in cognitively impaired patients, with fewer side effects. However, some community members prefer piracetam for its smoother profile and lower irritability risk.

Do I need to take a choline supplement with Noopept?
It is strongly recommended. Noopept's cholinergic mechanism may increase acetylcholine demand, and headaches are a common side effect without choline supplementation. Alpha-GPC (300-600 mg) or CDP-choline (250-500 mg) are the most commonly recommended options.

Why do some people not respond to Noopept?
Non-response is frequently reported and may relate to genetic variation, baseline cholinergic function, or dose. Research in mice showed strain-dependent effects, with DBA/2J mice (which have a cholinergic deficit) showing no response. The bimodal dose-response curve also means intermediate doses may be ineffective.

Can Noopept cause memory problems?
Paradoxically, yes. While Noopept's intended effect is memory enhancement, short-term memory impairment is one of the most commonly reported community side effects, particularly at higher doses. This appears to be dose-dependent and may relate to excessive glutamate receptor modulation.

How long can I take Noopept continuously?
The manufacturer recommends courses of 1.5-3 months followed by a 1-month break. The longest published human study is 56 days. Community experience suggests tolerance may develop with extended continuous use, and some users report this tolerance can persist for extended periods.

Myth vs. Fact

Myth: Noopept is 1,000 times more potent than piracetam.
Fact: This figure comes from a single German review abstract. The actual potency ratio varies considerably depending on the specific measure, ranging from 200x to 50,000x on a dose-per-dose basis. "Potent" in this context means it achieves effects at lower doses by weight, not that it is a thousand times more effective at improving cognition [11].

Myth: Noopept is a racetam.
Fact: Despite frequent classification with the racetam family, Noopept technically is not a racetam because it lacks the defining 2-oxo-pyrrolidine nucleus. It is more accurately described as a dipeptide analog of piracetam or a cycloprolylglycine prodrug [11].

Myth: Noopept will make healthy people smarter.
Fact: No published studies have examined Noopept in healthy humans or animals for cognitive enhancement. All positive human findings are in people with existing cognitive impairment from brain injury or vascular disease. Community reports from healthy users are mixed, with one systematic self-tester finding no objective cognitive improvement [11].

Myth: Noopept is a dietary supplement.
Fact: In the United States, the FDA has explicitly determined that Noopept does not qualify as a dietary supplement. It is a synthetic compound that the FDA considers a new unapproved drug. Products marketed as supplements continue to be sold online but this does not change their regulatory classification [7] [10].

Sources & References

Clinical Trials & RCTs

[1] Neznamov GG, Teleshova ES. "Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin." Neurosci Behav Physiol. 2009.

Reviews & Pharmacology

[2] Vakhitova YV, Sadovnikov SV, Borisevich SS, et al. "Molecular Mechanism Underlying the Action of Substituted Pro-Gly Dipeptide Noopept." Acta Naturae. 2016;8(1):82-89. PMC4837574.

[3] Ostrovskaya RU, et al. "Noopept stimulates the expression of NGF and BDNF in rat hippocampus." Bull Exp Biol Med. 2008;146(3):334-7. PMID: 19240853.

[4] "Effect of nootropic dipeptide noopept on CA1 pyramidal neurons." PMID: 36195298.

[5] Ostrovskaya RU, et al. "The nootropic and neuroprotective proline-containing dipeptide Noopept restores spatial memory and increases immunoreactivity to amyloid in an Alzheimer's Disease model." J Psychopharmacol. 2007;21:611-619. PMID: 17092975.

[6] Ostrovskaya RU, et al. "Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model." J Biomed Sci. 2014;21:74. PMC4422191.

Government / Institutional Sources

[7] FDA Warning Letter to Peak Nootropics LLC, February 2019.

[8] FDA Warning Letter to Crystal Clear Supplements, February 2022.

Safety & Adverse Events

[9] WADA 2026 Prohibited List.

[10] ConsumerLab.com. "What is Noopept? Can it really improve memory and cognition, and is it safe?" Last updated September 2020.

[11] Examine.com. "N-Phenylacetyl-L-prolylglycine ethyl ester (Noopept)." Last updated August 28, 2025.

Related Supplement Guides

Cross-links will be expanded as more supplement guides are published.

Same Category

• Piracetam — Structural parent compound

Common Stacks / Pairings

• Alpha-GPC — Choline source, commonly stacked
• CDP-Choline (Citicoline) — Alternative choline source
• L-Theanine — Commonly co-supplemented for anxiolytic support

Related Health Goal

• Bacopa Monnieri — Alternative evidence-based nootropic